Security key
252828108
Dianthus Therapeutics, Inc. /DE/ - Common Stock (DNTH)
CUSIP: 252828108
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 10,291,119
- Total 13F value
- $106,507,945
- Share change
- +82,998
- SEC-reported price per share
- $10.40
- Number of holders
- 38
- Value change
- +$518,588
- Number of buys
- 17
- Number of sells
- 7
- Shares outstanding
- 54,752,594
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
38
Top holders
10
DNTH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Dianthus Therapeutics, Inc. /DE/ SEC filings
Dianthus Therapeutics, Inc. /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 252828108
Recent filing periods:
Ownership snapshot
Top reported holders of DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
4.1%
Fairmount Funds Management LLC
3.5%
5AM Venture Management, LLC
2.7%
Avidity Partners Management LP
2.2%
Venrock Adviser, LLC
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
4.1%
|
$28,960,584
2,218,212 shares
|
— | 30 Sep 2023 |
| Fairmount Funds Management LLC |
13F
Company
|
3.5%
|
$26,362,636
1,928,503 shares
|
— | 30 Sep 2023 |
| 5AM Venture Management, LLC |
13F
Company
|
2.7%
|
$20,125,849
1,472,264 shares
|
— | 30 Sep 2023 |
| Avidity Partners Management LP |
13F
Company
|
2.2%
|
$16,643,963
1,217,554 shares
|
— | 30 Sep 2023 |
| Venrock Adviser, LLC |
13F
Company
|
1.7%
|
$12,681,741
927,706 shares
|
— | 30 Sep 2023 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
1.1%
|
$8,087,664
591,636 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
10,291,119
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
30
Q4 2023 holders
38
Holder diff
8
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend